about IPA

About IPA

The Indian Pharmaceutical Alliance (IPA) represents 23 leading research-based Indian pharmaceutical companies. IPA plays the role of a catalyst in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities.

Know more

Our Resources

  • Articles

    Generic & biosimilar industry to focus on expanding reach through emerging and traditional modalities: Expert

    August 20, 2021

  • Articles

    IP Alliance, CSIR organize 1st Pharmaceutical Innovation Exchange Forum

    August 20, 2021

  • External Studies and Reports

    A Vision for the Global Generic and Biosimilar Medicines Industry Whitepaper

    July 7, 2021

  • Position Papers

    IPA Submission – USTR Special 301 Report

    January 29, 2021

  • Position Papers

    IPA Employee Safety Initiatives Report

    January 25, 2021

  • External Studies and Reports

    Beyond Business – Contributions to Social Initiatives_IPA Samhita

    December 14, 2020

  • Presentations

    The Indian pharmaceutical industry and global market

    September 30, 2019

  • Presentations

    New International Healthcare Policies in Making Perspective from India – Warsaw

    June 13, 2019

Know more

Our Videos